Results 221 to 230 of about 1,262,069 (384)

The effect of diltiazem on coronary thrombosis in the conscious canine

, 1982
Michael J. Shea, Larry R. Bush, Joseph L. Romson, Edward M. Driscoll, Benedict R. Lucchesi   +4 more
openalex   +2 more sources

Late Stent Thrombosis After Drug-Coated Balloon Coronary Angioplasty for In-Stent Restenosis

, 2021
Wenjun Wang, Bailu Wang, Yuguo Chen, Shujian Wei   +3 more
openalex   +2 more sources

Hemocompatibility Outcomes After Aspirin Withdrawal in Long‐Term HeartMate 3 Left Ventricular Assist Device Patients on Vitamin K Antagonists

Artificial Organs, EarlyView.
Aspirin discontinuation in long‐term, stable Heart Mate 3 LVAD patients maintained on Vitamin K antagonists did not increase hemocompatibility‐related adverse events. These findings support the safety of simplified antithrombotic therapy and extend randomized evidence for aspirin avoidance to the long‐term management of Heart Mate 3 recipients ...
Melanie Arnreiter, Barbara Karner, Hebe Al Asadi, Christina Abd El‐Malak, Christiane Marko, Daniel Zimpfer, Julia Riebandt, Roxana Moayedifar, Thomas Schlöglhofer   +8 more
wiley   +1 more source

A case of acute coronary syndrome secondary to cocaine-induced coronary thrombosis. [PDF]

Eur Heart J Case Rep
Morsy M, Fyyaz S, Olaru MM, Marciniak M.
europepmc   +1 more source

Hemocompatibility and Long‐Term Outcomes in HeartWare Versus HeartMate II Versus HeartMate 3: Multicenter Real‐World Cohort

Artificial Organs, EarlyView.
Multicenter real‐world cohort (n = 327) comparing LVADs: HeartMate 3 (HM3), HeartMate II (HMII), and HeartWare (HVAD). HM3 showed superior long‐term survival versus legacy devices, driven by fewer hemocompatibility‐related adverse events, especially pump thrombosis and ischemic stroke, while major bleeding was similar across devices.
Hamza H. H. Ben Nasir, Ahmed F. A. Mohammed, Omar Allham, Alish Kolashov, Yusuf Shieba, Lachmandath Tewarie, Bernd Panholzer, Ajay Moza, Assad Haneya, Rashad Zayat   +9 more
wiley   +1 more source

Very Late Coronary Thrombosis After Drug-Coated Balloon Treatment: An Old Problem With a New Therapy. [PDF]

JACC Case Rep
Velazquez Gutierrez GJ, Occhipinti G, Sabaté Tenas M, Brugaletta S.   +3 more
europepmc   +1 more source

Mechanisms of Coronary Thrombosis in Cigarette Smoke Exposure

Arteriosclerosis, Thrombosis and Vascular Biology, 2013
Rajat S Barua, J. Ambrose
semanticscholar   +1 more source

Does Gastrointestinal Bleeding Increase the Risk of Thromboembolic Events in Patients Supported With CF‐LVADs?

Artificial Organs, EarlyView.
Gastrointestinal bleeding significantly increases thromboembolic risk. Higher risk was also seen in patients aged ≥ 50 years, Black patients, and those with older CF‐LVAD models. ABSTRACT Background Gastrointestinal bleeding is a common complication in continuous‐flow left ventricular assist device (CF‐LVAD) patients. Managing gastrointestinal bleeding
Anh Nguyen, Alexis Shafii, Gabriel Loor, Subhasis Chatterjee, Andrew Civitello, O. Howard Frazier, Kenneth Liao   +6 more
wiley   +1 more source

Massive coronary thrombosis caused primary percutaneous coronary intervention to fail in a COVID-19 patient with ST-elevation myocardial infarction. [PDF]

Catheter Cardiovasc Interv, 2021
Seif S, Ayuna A, Kumar A, Macdonald J.
europepmc   +1 more source

Coronary sinus thrombosis in a patient with amyloidosis, the role of multimodality imaging: a case report [PDF]

Alejandro Manuel López-Pena, Rosa Alba Abellás-Sequeiros, Andrea López‐López, Jeremías Bayón-Lorenzo, Carlos González‐Juanatey   +4 more
openalex   +1 more source